Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers (NCT07738991) | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. | 2026-07-03 |
| A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA® (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants Under Fasting Conditions (NCT07147257) | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. | 2025-02-12 |
Track Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.